ESWT is associated with significantly increased odds of reduced plaques and pain relief.
Extracorporeal shockwave therapy (ESWT) may be a safe and effective treatment for reducing penile plaques and relieving pain in men with Peyronie’s disease, according to a new meta-analysis published online in the International Journal of Impotence Research.
The meta-analysis, by Liang Gao, MD,and colleagues at Sichuan University in Sichuan, China, included 6 studies that included 443 patients. Pooled data from these studies showed that ESWT was associated with a significant 2-fold increased odds of lessening of plaques, 4.5-fold increased odds of pain relief, and 5.9-fold increased odds of complete remission of pain, the investigators reported. ESWT was not associated with improved penile curvature and sexual function.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.